Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Hubei Jumpcan Pharmaceutical Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥340 Mil. Hubei Jumpcan Pharmaceutical Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-6 Mil.
Hubei Jumpcan Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2026 was 55.14.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Hubei Jumpcan Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Hubei Jumpcan Pharmaceutical Co's Interest Coverage or its related term are showing as below:
SHSE:600566'
s Interest Coverage Range Over the Past 10 Years
Min: 42.43 Med: 82.34 Max: 9390.13
Current: 129.21
SHSE:600566's Interest Coverage is ranked better than 81.17% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs SHSE:600566: 129.21
Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Hubei Jumpcan Pharmaceutical Co Interest Coverage Related Terms
Hubei Jumpcan Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Hubei Jumpcan Pharmaceutical Co Interest Coverage Chart
SHSE:600566 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Jumpcan Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Jumpcan Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hubei Jumpcan Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Hubei Jumpcan Pharmaceutical Co's Interest Coverage falls into.
Hubei Jumpcan Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Jumpcan Pharmaceutical Co (SHSE:600566) has a Interest Coverage of 55.14 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. This is 33% below median its historical median of 82.34. Over the past decade, Hubei Jumpcan Pharmaceutical Co's Interest Coverage has ranged from 42.43 to 9,390.13. According to the industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #129 out of 685 companies in the Drug Manufacturers industry, placing it in the top 18.8%.
Is Hubei Jumpcan Pharmaceutical Co's Interest Coverage too high?
Hubei Jumpcan Pharmaceutical Co's current Interest Coverage of 55.14 is 33% below median its 10-year median of 82.34. Over the past 10 years, this metric has ranged from a low of 42.43 to a high of 9,390.13. The Drug Manufacturers industry median Interest Coverage is 12.75. Hubei Jumpcan Pharmaceutical Co's value of 55.14 is 332.5% above this industry median. Based on the distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #129 out of 685 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hubei Jumpcan Pharmaceutical Co has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hubei Jumpcan Pharmaceutical Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #129 out of 685 companies for Interest Coverage. This places Hubei Jumpcan Pharmaceutical Co in the top 19% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.75. Hubei Jumpcan Pharmaceutical Co's value of 55.14 is 332.5% above this benchmark. Historically, Hubei Jumpcan Pharmaceutical Co's own Interest Coverage has ranged from 42.43 to 9,390.13 over the past decade. While the company's 10-year median is 82.34 vs. the industry median of 12.75, Hubei Jumpcan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hubei Jumpcan Pharmaceutical Co's current Interest Coverage of 55.14 is 332.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hubei Jumpcan Pharmaceutical Co's current Interest Coverage is 55.14, which is 33% below median its own 10-year median of 82.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Jumpcan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co (SHSE:600566) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥20.95, compared to a current price of ¥24.10 — trading 15% above its estimated fair value. The current Interest Coverage is 55.14, which is 33% below median its 10-year median of 82.34 and 332.5% above the Drug Manufacturers industry median of 12.75. Hubei Jumpcan Pharmaceutical Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Hubei Jumpcan Pharmaceutical Co (SHSE:600566), the current Interest Coverage is 55.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Overvalued in 2026?
Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥24.10 is trading 15% above its estimated GF Value™ of ¥20.95.
GuruFocus considers Hubei Jumpcan Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for SHSE:600566:
Interest Coverage: 55.14 (33% below median its 10-year median of 82.34)
GF Value™: ¥20.95 vs. price of ¥24.10 (15% above fair value)
Industry Position: 332.5% above the Drug Manufacturers median (#129 of 685)
No single metric tells the full story. See the SHSE:600566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hubei Jumpcan Pharmaceutical Co Business Description
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemicals based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and Western medicines in the areas of pediatrics, gynecology, pneumonology, gastroenterology, and geriatrics. The company also develops Chinese and Western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
86GF Score
Get the complete analysis for SHSE:600566
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600566 has been successfully added to your 
